Altimmune Stock Quote ALT - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

7.20

Bid

7.15

Ask

7.27

Volume

2,250,760

6.90 Day's Range 7.42

2.09 52 Week Range 14.84

Market Cap

390.072M

Previous Close

7.20

Open

7.18

Last Trade

7.27

Last Trade Time

Financial Volume

$ 16,207,749

VWAP

7.201

Average Volume (3m)

4,736,954

Shares Outstanding

53,728,871

Dividend Yield

PE Ratio

-4.41

Earnings Per Share (EPS)

-1.65

Revenue

426k

Net Profit

-88.45M

Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the tre... Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV). Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.altimmune.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Altimmune Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALT. The last closing price for Altimmune was $7.20. Over the last year, Altimmune shares have traded in a share price range of $ 2.09 to $ 14.84.

Altimmune currently has 53,728,871 shares outstanding. The market capitalization of Altimmune is $390.07 million. Altimmune has a price to earnings ratio (PE ratio) of -4.41.

Overall Flow

Bearish

Net Premium

-218k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Altimmune Statement on the Passing of Dr. Stephen Harrison

GAITHERSBURG, Md., April 25, 2024 (GLOBE NEWSWIRE) -- The Altimmune team would like to express our sorrow and extend our heartfelt condolences to Dr. Stephen Harrison’s family following his...

Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results

Body composition study showed lean mass preservation, with only 25.5% of weight loss derived from lean mass Enrollment ongoing in IMPACT Phase 2b trial of pemvidutide in Metabolic...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.35	5.10948905109	6.85	8.23	6.64	2692024	7.23593244	CS
4	-3.05	-29.756097561	10.25	11.01	6.64	3018995	8.15537954	CS
12	-2.41	-25.0780437045	9.61	14.84	6.64	4736954	9.98763054	CS
26	4.55	171.698113208	2.65	14.84	2.24	7802894	7.94520085	CS
52	1.96	37.4045801527	5.24	14.84	2.09	4620402	7.25747898	CS
156	-5.53	-43.4406912804	12.73	23.49	2.09	2551545	8.90553299	CS
260	4.51	167.657992565	2.69	35.1	1.45	2140605	10.14089098	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M